Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 95.75
-0.45 (-0.47%)
Jun 12, 2026, 5:29 PM CET
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of 12.97 billion as of June 12, 2026. Its market cap has decreased by -37.82% in one year.
Market Cap
12.97B
Enterprise Value
13.66B
Revenue
3.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
95.75
Market Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 510.85M to 12.97B, an increase of 2,438.26%. That is a compound annual growth rate of 13.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 12.97B | -30.11% |
| Dec 30, 2025 | 18.55B | -36.27% |
| Dec 30, 2024 | 29.11B | 10.43% |
| Dec 29, 2023 | 26.36B | 4.56% |
| Dec 30, 2022 | 25.21B | -66.75% |
| Dec 30, 2021 | 75.82B | 223.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 58.19B |
| Getinge AB | 53.45B |
| Elekta AB | 20.02B |
| Nolato AB | 13.19B |
| Xvivo Perfusion AB | 8.60B |
| MedCap AB | 7.47B |
| CellaVision AB | 3.30B |
| Devyser Diagnostics AB | 1.51B |